We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
-2.35%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.85B
AUM Growth
+$132M
Cap. Flow
+$223M
Cap. Flow %
7.84%
Top 10 Hldgs %
64.12%
Holding
111
New
25
Increased
23
Reduced
13
Closed
26

Top Buys

Rank Stock Value
1
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$172M
2
MET icon
MetLife
MET
+$21.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$13.5M
4
AIG icon
American International
AIG
+$13.4M
5
DG icon
Dollar General
DG
+$13M

Top Sells

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$32.6M
2
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$28.1M
3
IMGN
Immunogen Inc
IMGN
+$13.7M
4
BABA icon
Alibaba
BABA
+$12.8M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$8.93M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.65%
2 Healthcare 21.49%
3 Financials 2.87%
4 Communication Services 1.25%
5 Industrials 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NG icon
76
CALL
NovaGold Resources
NG
$2.51B
$2.95M 0.1%
1,000,000
– –
CSLT
77
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.92M 0.1%
250,000
– –
RXDX
78
DELISTED
Ignyta, Inc.
RXDX
$2.74M 0.1%
400,000
+25,000
+7% +$170K
CCXI
79
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
$2.73M 0.1%
400,000
+300,000
+300% +$1.59M
CCXI
80
DELISTED
ChemoCentryx, Inc.
CCXI
$2.73M 0.1%
400,000
+125,000
+45% +$661K
PARN
81
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$2.08M 0.07%
500,000
– –
CERE
82
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$1.97M 0.07%
1,024,021
– –
AGEN
83
Agenus
AGEN
$279M
$1.63M 0.06%
20,896
– –
ARRY
84
CALL
DELISTED
Array Biopharma Inc
ARRY
$1.47M 0.05%
+310,000
New +$1.23M
AMRN
85
CALL
Amarin Corp
AMRN
$303M
$490K 0.02%
25,000
– –
CFG icon
86
Citizens Financial Group
CFG
$30.5B
– –
-150,000
Closed -$3.51M
CPRI icon
87
Capri Holdings
CPRI
$1.79B
– –
-50,000
Closed -$3.57M
CTSH icon
88
CALL
Cognizant
CTSH
$25.6B
– –
-300,000
Closed -$13.4M
HOG icon
89
Harley-Davidson
HOG
$2.61B
– –
-100,000
Closed -$5.82M
HON icon
90
CALL
Honeywell
HON
$77B
– –
-166,934
Closed -$14M
ITB icon
91
CALL
iShares US Home Construction ETF
ITB
$2.35B
– –
-750,000
Closed -$16.9M
MS icon
92
CALL
Morgan Stanley
MS
$323B
– –
-150,000
Closed -$5.19M
NEOG icon
93
Neogen
NEOG
$2B
– –
-333,333
Closed -$4.94M
OUT icon
94
Outfront Media
OUT
$5.8B
– –
-87,017
Closed -$1.95M
QCOM icon
95
CALL
Qualcomm
QCOM
$169B
– –
-200,000
Closed -$15M
RL icon
96
Ralph Lauren
RL
$22.2B
– –
-25,000
Closed -$4.12M
UAL icon
97
CALL
United Airlines
UAL
$39.5B
– –
-200,000
Closed -$9.36M
V icon
98
CALL
Visa
V
$701B
– –
-280,000
Closed -$14.9M
VMC icon
99
CALL
Vulcan Materials
VMC
$37.5B
– –
-400,000
Closed -$24.1M
XLI icon
100
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$32.7B
– –
-500,000
Closed -$26.6M
1 2 3
4
5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q4 2014 Portfolio in Review

As of Q4 2014, Artal Group held 111 positions worth $2.85B, up 4.9% from $2.72B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Artal Group deployed $223M of net new capital in Q4 2014, opening 25 new positions and adding to 23 existing holdings. Its largest new stake was MetLife: 448,800 shares worth $21.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $12.8M trimmed.

  • Artal Group's largest Q4 2014 buy was MetLife: 448,800 shares worth $21.6M.
  • Artal Group added most to Lexicon Pharmaceuticals in Q4 2014, an estimated $172M increase.
  • Artal Group's biggest Q4 2014 reduction was Alibaba, cutting an estimated $12.8M.
  • Artal Group fully exited AUXILIUM PHARAMCEUTICALS INC in Q4 2014, selling an estimated $32.6M.
  • Artal Group's ten largest holdings make up 64% of its $2.85B portfolio in Q4 2014.
  • Artal Group opened 25 new positions and closed 26 in Q4 2014.
  • Artal Group's portfolio value rose 4.9% quarter-over-quarter to $2.85B.

Based on Artal Group's 13F filing for Q4 2014, filed 13 Feb 2015.